Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Medicus Pharma Ltd. Commo...

    NASDAQ: MDCX · Real-Time Price · USD
    2.52
    -0.06 (-2.33%)
    At close: Jun 20, 2025, 3:59 PM
    2.58
    2.58%
    Pre-market: Jun 23, 2025, 07:48 AM EDT
    -2.33%
    Bid 2.42
    Market Cap 39.82M
    Revenue (ttm) n/a
    Net Income (ttm) -9.36M
    EPS (ttm) -1.37
    PE Ratio (ttm) -1.84
    Forward PE -2.69
    Analyst Strong Buy
    Ask 2.68
    Volume 176,912
    Avg. Volume (20D) 213,070
    Open 2.63
    Previous Close 2.58
    Day's Range 2.45 - 2.65
    52-Week Range 1.80 - 8.94
    Beta -2.57

    About MDCX

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol MDCX
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for MDCX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 weeks ago
    -29.95%
    Medicus Pharma shares are trading lower after the ... Unlock content with Pro Subscription
    3 weeks ago
    -15.5%
    Medicus Pharma shares are trading lower after the company announced a 3.7 million share offering.
    news image

    1 week ago · proactiveinvestors.com

    Medicus Pharma targets horse cancer with new trial – ICYMI

    Medicus Pharma (NASDAQ:MDCX) earlier this week announced the submission of a veterinary clinical development program to the FDA targeting squamous cell carcinoma in horses. The move follows the compan...

    news image

    1 week ago · newsfilecorp.com

    Medicus Pharma Ltd. to Present at 2025 Bio International Convention

    Company Executive Chairman & CEO to Provide Corporate Updates on June 17th 2025 Philadelphia, Pennsylvania--(Newsfile Corp. - June 12, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Com...

    news image

    1 week ago · proactiveinvestors.com

    Medicus Pharma submits FDA plan to develop microneedle-based treatment for skin cancer in horses

    Medicus Pharma (NASDAQ:MDCX) said on Monday it has submitted a comprehensive product development plan to the US Food and Drug Administration (FDA) to advance its investigational treatment for external...

    news image

    1 week ago · newsfilecorp.com

    Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses

    Company Is Advancing Use of Novel Doxorubicin-containing Microneedle Array (D-MNA) Patch in Veterinary Oncology as an Orphan Drug Philadelphia, Pennsylvania--(Newsfile Corp. - June 9, 2025) - Medicus ...

    news image

    2 weeks ago · proactiveinvestors.com

    Medicus Pharma appoints KPMG as new auditor, expands global clinical programs

    Medicus Pharma (NASDAQ:MDCX) said it has appointed KPMG as its independent registered public accounting firm for the 2025 fiscal year, replacing EisnerAmper following a review process led by the compa...

    news image

    3 weeks ago · newsfilecorp.com

    Medicus Pharma Ltd. Announces Closing of $7.0 Million Public Offering

    Philadelphia, Pennsylvania--(Newsfile Corp. - June 2, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the closing of its previously announced public offering of 2,260,000 un...

    news image

    3 weeks ago · proactiveinvestors.com

    Medicus Pharma unveils pricing of $7M public offering

    Medicus Pharma (NASDAQ:MDCX) has announced the pricing of its $7 million public offering of 2.26 million shares on a “best-efforts” basis at $3.10 per unit. Each unit includes one share and one warran...

    news image

    3 weeks ago · newsfilecorp.com

    Medicus Pharma Ltd. Announces Pricing of $7.0 Million Public Offering

    Philadelphia, Pennsylvania--(Newsfile Corp. - May 29, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of its public offering of 2,260,000 units, on a "best-effor...

    news image

    4 weeks ago · proactiveinvestors.com

    Medicus Pharma begins UAE cancer trial expansion – ICYMI

    Medicus Pharma (NASDAQ:MDCX) CEO Raza Bokhari talked with Proactive about the company's newly announced regulatory approval to expand its Phase 2 trial into the United Arab Emirates. The study is focu...

    news image

    1 month ago · proactiveinvestors.com

    Medicus Pharma gets UAE approval for Phase 2 study for skin cancer therapy

    Medicus Pharma (NASDAQ:MDCX) has received regulatory approval from the UAE Department of Health to begin a Phase 2 clinical trial evaluating its non-invasive therapy for basal cell carcinoma (BCC) of ...

    Add to Watchlist